RSPO3 and intestinal neoplasm: Adding up to the oncogenic capacity of Rspo3 overexpression, another mouse study showed that also the transgenic expression of either EIF3E-RSPO2 or PTPRK-RSPO3 gene fusion causally drives the formation of intestinal tumors, which comparably show expansion of proliferative cells and ectopic Paneth cells [57].